Prophylactic dexamethasone for radiation-induced bone-pain flare - Authors' reply.

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  N. Sugimoto,et al.  S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial. , 2016, The Lancet Oncology.

[3]  K. Ding,et al.  Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. , 2015, The Lancet. Oncology.

[4]  K Nishikawa,et al.  Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  L. Laine.  NSAID-associated gastrointestinal bleeding: assessing the role of concomitant medications. , 2014, Gastroenterology.

[6]  J. Lei,et al.  Risk of upper gastrointestinal bleeding from different drug combinations. , 2014, Gastroenterology.

[7]  G. Fiorentini,et al.  Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis , 2011, Gastric Cancer.

[8]  A. Fairchild,et al.  Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[9]  C. Bokemeyer,et al.  Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  T. Panzarella,et al.  Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases—a pilot study , 2007, Supportive Care in Cancer.

[11]  M. Buyse,et al.  Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.